反应详情

A solution of (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one (140 mg) in THF (7 ml) under nitrogen was treated with potassium trimethylsilanolate (130 mg) and the mixture was heated (oil bath temperature 80°) with stirring for 3 h. The mixture was cooled to 20° and was partitioned between phosphate buffer solution (20 ml, pH6.5) and EtOAc (20 ml). The organic phase was separated, dried (NaSO4) and the solvent evaporated in vacuo to give the title compound (130 mg). LCMS RT=3.00 min.

1. temperaturethe mixture was heated (oil bath temperature 80°)
2. temperatureThe mixture was cooled to 20°
3. customwas partitioned between phosphate buffer solution (20 ml, pH6.5) and EtOAc (20 ml)
4. customThe organic phase was separated
5. dry with materialdried (NaSO4)
6. customthe solvent evaporated in vacuo